Results 221 to 230 of about 6,359,259 (380)
A Pathologist's Dilemma: Placental Site Tumor and Its Differential Diagnosis. [PDF]
Daoudi C+4 more
europepmc +1 more source
DIFFERENTIAL DIAGNOSIS BETWEEN SMALL-POX AND CHICKEN-POX. [PDF]
GeorgeSteele Perkins
openalex +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
Abstract The present study was conducted as part of a comprehensive work to establish National Diagnostic Reference Levels (NDRLs) in Sri Lanka for the first time. DRLs can be used as an effective optimization tool for identifying unusually high or low patient doses during X‐ray examinations.
Sachith Welarathna+3 more
wiley +1 more source
Chiari Malformation as a Differential Diagnosis of Recurrent Syncope. [PDF]
Figueiredo F+6 more
europepmc +1 more source
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
Frontotemporal dementia: a systematic review of artificial intelligence approaches in differential diagnosis. [PDF]
Dattola S+5 more
europepmc +1 more source
The Differential Diagnosis of Tuberculo-Silicosis
E. H. Kettle, H. E. Archer
openalex +1 more source
THE DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF PULMONARY ABSCESS AND GANGRENE, WITH VIEW TO SURGICAL TREATMENT. [PDF]
Robert H. Babcock
openalex +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source